New Mexico § 26-1-13 - Packaging and labeling requirements; proprietary preparations

§ 26-1-13. Packaging and labeling requirements; proprietary preparations

A. The principal display panel of an over-the-counter packaged drug or device shall

bear as one of its principal features a statement of the identity of the commodity. The statement shall include the established name of the drug or the common name

of the device and an accurate statement of the general pharmacological category of

the drug or the principal intended action of the drug or device in terms meaningful

to the layman. B. In the case of an over-the-counter drug that is a mixture with no established name,

a conspicuous enumeration of each active ingredient that is a mixture with no established

name and a conspicuous enumeration of each active ingredient immediately followed

by an accurate statement of the general pharmacological category of the ingredients

or of its principal intended action in terms that are meaningful to the layman. C. This section shall not apply to any drug or class of drugs exempted by regulations

promulgated under the federal Fair Packaging and Labeling Act. 1 D. The label of an over-the-counter packaged drug or device shall bear a declaration

of the net quantity of its contents. E. Dangerous drugs or over-the-counter preparations subject to the federal Poison

Prevention Packaging Act of 1970 shall meet the safety closure standards and regulations

promulgated pursuant to the federal Poison Prevention Packaging Act of 1970. 2 1

15 U.S.C.A. § 1451 et seq. 2

15 U.S.C.A. § 1471 et seq.